Select Publications
Journal articles
2024, 'Vaccination coverage among people who inject drugs: A systematic review', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104382
,2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', The Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7
,2024, 'Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence', International Journal of Drug Policy, 126, http://dx.doi.org/10.1016/j.drugpo.2024.104359
,2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.', Int J Drug Policy, 127, pp. 104390, http://dx.doi.org/10.1016/j.drugpo.2024.104390
,2024, 'Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study', Value in Health, 27, pp. 216 - 225, http://dx.doi.org/10.1016/j.jval.2023.10.013
,2024, 'Age-Related Risk of Serious Fall Events and Opioid Analgesic Use', JAMA Internal Medicine, http://dx.doi.org/10.1001/jamainternmed.2023.8154
,2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13823
,2024, 'Prescription opioid use among people with opioid dependence and concurrent benzodiazepine and gabapentinoid exposure: An analysis of overdose and all-cause mortality', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104287
,2024, 'Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022', International Journal of Drug Policy, 123, http://dx.doi.org/10.1016/j.drugpo.2023.104255
,2024, 'High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs', Vaccine, http://dx.doi.org/10.1016/j.vaccine.2024.03.051
,2023, 'Determinants of effective treatment coverage for posttraumatic stress disorder: findings from the World Mental Health Surveys', BMC Psychiatry, 23, http://dx.doi.org/10.1186/s12888-023-04605-2
,2023, 'Educational level and the risk of mental disorders, substance use disorders and self-harm in different age-groups: A cohort study covering 1,6 million subjects in the Stockholm region', International Journal of Methods in Psychiatric Research, 32, http://dx.doi.org/10.1002/mpr.1964
,2023, 'Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia', International Journal of Drug Policy, 122, http://dx.doi.org/10.1016/j.drugpo.2023.104218
,2023, 'Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review', The Lancet Global Health, 11, pp. e1885 - e1898, http://dx.doi.org/10.1016/S2214-109X(23)00461-8
,2023, 'Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): A cluster randomised controlled trial protocol', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2023-075286
,2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723
,2023, 'Prevalence of opioid dependence in New South Wales, Australia, 2014–16: Indirect estimation from multiple data sources using a Bayesian approach', Addiction, 118, pp. 1994 - 2006, http://dx.doi.org/10.1111/add.16268
,2023, 'Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries', The Lancet Psychiatry, 10, pp. 668 - 681, http://dx.doi.org/10.1016/S2215-0366(23)00193-1
,2023, 'Agreement between self-reported illicit drug use and biological samples: a systematic review and meta-analysis', Addiction, 118, pp. 1624 - 1648, http://dx.doi.org/10.1111/add.16200
,2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218
,2023, 'International monitoring of capacity of treatment systems for alcohol and drug use disorders: Methodology of the Service Capacity Index for Substance Use Disorders', International Journal of Methods in Psychiatric Research, 32, http://dx.doi.org/10.1002/mpr.1950
,2023, 'Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality', Drug and Alcohol Review, 42, pp. 1461 - 1471, http://dx.doi.org/10.1111/dar.13669
,2023, 'Opioid prescribing patterns among medical practitioners in New South Wales, Australia', Drug and Alcohol Review, 42, pp. 1472 - 1481, http://dx.doi.org/10.1111/dar.13675
,2023, 'Perspectives and sentiments on contingency management from people who use methamphetamine', Drug and Alcohol Review, 42, pp. 1427 - 1437, http://dx.doi.org/10.1111/dar.13691
,2023, 'Five-Year Trajectories of Prescription Opioid Use', JAMA Network Open, 6, pp. E2328159, http://dx.doi.org/10.1001/jamanetworkopen.2023.28159
,2023, 'Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002–17', Addiction, 118, pp. 1527 - 1539, http://dx.doi.org/10.1111/add.16178
,2023, 'Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies', The Lancet Psychiatry, 10, pp. 386 - 402, http://dx.doi.org/10.1016/S2215-0366(23)00095-0
,2023, 'Substance use among vocational trainees in Australia: differences between medical specialties', Internal Medicine Journal, 53, pp. 939 - 945, http://dx.doi.org/10.1111/imj.15729
,2023, 'Cohort profile: POPPY II - A population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-068310
,2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002
,2023, 'Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users', Schizophrenia Bulletin, 49, pp. 778 - 787, http://dx.doi.org/10.1093/schbul/sbac196
,2023, 'Development and evaluation of a risk algorithm predicting alcohol dependence after early onset of regular alcohol use', Addiction, 118, pp. 954 - 966, http://dx.doi.org/10.1111/add.16122
,2023, 'Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review', The Lancet Global Health, 11, pp. e659 - e672, http://dx.doi.org/10.1016/S2214-109X(23)00057-8
,2023, 'Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review', The Lancet Global Health, 11, pp. e673 - e683, http://dx.doi.org/10.1016/S2214-109X(23)00058-X
,2023, 'Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study', Drug and Alcohol Dependence, 246, http://dx.doi.org/10.1016/j.drugalcdep.2023.109851
,2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998
,2023, 'A data-informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data', Pharmacoepidemiology and Drug Safety, 32, pp. 352 - 365, http://dx.doi.org/10.1002/pds.5567
,2023, 'Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis', Drug and Alcohol Review, 42, pp. 569 - 581, http://dx.doi.org/10.1111/dar.13595
,2023, 'Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions', International Journal of Drug Policy, 113, http://dx.doi.org/10.1016/j.drugpo.2023.103976
,2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959
,2023, 'The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence', Drug and Alcohol Dependence, 243, http://dx.doi.org/10.1016/j.drugalcdep.2022.109734
,2023, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13688
,2023, 'Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103917
,2022, '‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians', Addiction Science and Clinical Practice, 17, http://dx.doi.org/10.1186/s13722-022-00298-2
,2022, '“Frustrated with the whole system”: a qualitative framework analysis of the issues faced by people accessing health services for chronic pain', BMC Health Services Research, 22, http://dx.doi.org/10.1186/s12913-022-08946-8
,2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876
,2022, 'Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-21003-y
,2022, 'Age at first alcohol-related hospital separation or emergency department presentation and rate of re-admission: A retrospective data linkage cohort of young Australians', Drug and Alcohol Review, 41, pp. 1577 - 1588, http://dx.doi.org/10.1111/dar.13529
,2022, 'Increased risks for mental disorders among LGB individuals: cross-national evidence from the World Mental Health Surveys', Social Psychiatry and Psychiatric Epidemiology, 57, pp. 2319 - 2332, http://dx.doi.org/10.1007/s00127-022-02320-z
,2022, 'The associations between traumatic experiences and subsequent onset of a substance use disorder: Findings from the World Health Organization World Mental Health surveys', Drug and Alcohol Dependence, 240, http://dx.doi.org/10.1016/j.drugalcdep.2022.109574
,